Breaking News, Collaborations & Alliances

MMIC to Develop Platform for Quicker Optimization of OSD Formulations

Partnership between CPI, University of Strathclyde, GSK and AstraZeneca to utilize continuous manufacturing process.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

CPI and the University of Strathclyde, in strategic partnership with GSK and AstraZeneca, said that work has begun on Grand Challenge 1, a project to develop an innovative continuous direct compression (CDC) platform at the new Medicines Manufacturing Innovation Center (MMIC). The platform will enable oral solid dosage medicines to be formulated more robustly and efficiently.   CDC is a continuous manufacturing process that allows much greater process control than traditional batch-type pharmace...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters